On the Mitigation of Ni3+-Induced Losses in NiO Hole Transport Layers for Metal Halide Perovskite Solar Cells
ACS Applied Energy Materials · 09.11.2026 · 9 (21) · 14227-14242
DOI: 10.1021/acsaem.6c02443 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Energy Materials, online erschienen am 25.10.2026. Verfasst von Kousumi Mukherjee und 8 weiteren Autor:innen. Die Arbeit nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministerio de Ciencia, Innovaci?n y Universidades, European Commission, Horizon 2020 Framework Programme.
Abstract (Originalsprache)
NiO is widely investigated as a hole transport layer (HTL) in p–i–n metal halide perovskite solar cells. While previous studies have focused on improving device performance by lowering NiO film resistivity through increased Ni3+ content, Ni3+ states, particularly at the NiO surface, act as trap states and trigger redox reactions with the perovskite. This study investigates the performance of devices based on plasma-assisted atomic layer deposited (ALD) NiO film, NiOAlanis, characterized by a ∼2.7% higher relative average Ni valence and low resistivity (4 ± 1 Ω∙cm), compared to thermal ALD NiO film, NiOBu-MeAMD ((1.9 ± 0.3) × 104 Ω∙cm). NiOAlanis-based devices yield a poor power conversion efficiency (PCE) of ∼2.4%, compared to devices based on NiOBu-MeAMD (∼14.0%) and commonly used Me-4PACz (∼17.1%) or PTAA (~15.6%), primarily due to a low JSC (∼4.5 mA/cm2). X-ray photoelectron spectroscopy reveals that a redox reaction occurs between formamidinium iodide of the perovskite and Ni3+ states of NiOAlanis, leading to an interfacial charge-extraction barrier. To improve device performance, we report on an H2 plasma treatment of NiOAlanis (“NiOAlanis,H2 pl.”), which decreases the average Ni valence to ∼2.2%, relative to NiOBu-MeAMD, and increases the resistivity to (1.1 ± 0.1) × 104 Ω∙cm, indicating a decrease in relative Ni3+ content. Consequently, NiOAlanis,H2 pl.-based devices show improved charge collection, increasing the JSC to ∼20.5 mA/cm2 and leading to a PCE of ∼15.1%. Moreover, incorporating H2 plasma treatment in every ALD cycle (“NiOAlanis,ABC H2pl.”) further lowers the relative Ni3+ content owing to an increase in hydrogen content from 3 ± 1 to 9 ± 1 at./nm3 and increases the resistivity beyond the detection limit. Notably, NiOAlanis,ABC H2pl.-based devices recover a ∼110 mV VOC deficit typically observed in other NiO-based devices, achieving values comparable to those of PTAA- or NiO/Me-4PACz-based devices, due to suppression of interfacial redox reactions. Our results suggest that focusing on Ni3+ content suppression as well as interfacial passivation can provide a pathway towards high-performing devices.
Förderung
- Ministerio de Ciencia, Innovaci?n y Universidades
- European Commission
- Horizon 2020 Framework Programme
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek
- Ministerie van Economische Zaken en Klimaat
Zitieren
APA
Mukherjee, K., Driessen, T., Kreugel, D., Weijtens, C. H. L., Gargiani, P., Ersek, G., Portale, G., Zardetto, V., & Creatore, M. (2026). On the Mitigation of Ni3+-Induced Losses in NiO Hole Transport Layers for Metal Halide Perovskite Solar Cells. ACS Applied Energy Materials, 9(21), 14227-14242. https://doi.org/10.1021/acsaem.6c02443
Vancouver
Mukherjee K, Driessen T, Kreugel D, Weijtens CHL, Gargiani P, Ersek G, et al. On the Mitigation of Ni3+-Induced Losses in NiO Hole Transport Layers for Metal Halide Perovskite Solar Cells. ACS Applied Energy Materials. 2026;9(21):14227-14242. doi:10.1021/acsaem.6c02443
BibTeX
@article{Mukherjee2026,
author = {Mukherjee, Kousumi and Driessen, Thomas and Kreugel, Denise and Weijtens, Christ H. L. and Gargiani, Pierluigi and Ersek, Gabor and Portale, Giuseppe and Zardetto, Valerio and Creatore, Mariadriana},
title = {On the Mitigation of Ni3+-Induced Losses in NiO Hole Transport Layers for Metal Halide Perovskite Solar Cells},
journal = {ACS Applied Energy Materials},
year = {2026},
volume = {9},
number = {21},
pages = {14227--14242},
doi = {10.1021/acsaem.6c02443}
}
EUVIMED